Scrambled Prion Domains Form Prions and Amyloid

REFERENCES

• Bauer, H. H., Aebi U., Haner M., Hermann R., Muller M., and Merkle H. P.. 1995. Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin. J. Struct. Biol. 115:1–15.
   PubMed Web of Science ®Google Scholar
• Baxa, U., Speransky V., Steven A. C., and Wickner R. B.. 2002. Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein. Proc. Natl. Acad. Sci. USA 99:5253–5260.
   PubMed Web of Science ®Google Scholar
• Baxa, U., Taylor K. L., Wall J. S., Simon M. N., Cheng N., Wickner R. B., and Steven A. C.. 2003. Architecture of Ure2p prion filaments: the N-terminal domains form a central core fiber. J. Biol. Chem. 278:43717–43727.
   PubMed Web of Science ®Google Scholar
• Borchsenius, A. S., Wegrzyn R. D., Newnam G. P., Inge-Vechtomov S. G., and Chernoff Y. O.. 2001. Yeast prion protein derivative defective in aggregate shearing and production of new “seeds. ” EMBO J. 20:6683–6691.
   PubMed Web of Science ®Google Scholar
• Bousset, L., Belrhali H., Janin J., Melki R., and Morera S.. 2001. Structure of the globular region of the prion protein Ure2 from the yeast Saccharomyces cerevisiae. Structure 9:39–46.
   PubMed Web of Science ®Google Scholar
• Bousset, L., Thomson N. H., Radford S. E., and Melki R.. 2002. The yeast prion Ure2p retains its native alpha-helical conformation upon assembly into protein fibrils in vitro. EMBO J. 21:2903–2911.
   PubMed Web of Science ®Google Scholar
• Chiti, F., Stefani M., Taddei N., Ramponi G., and Dobson C. M.. 2003. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424:805–808.
   PubMed Web of Science ®Google Scholar
• Conde, J., and Fink G. R.. 1976. A mutant of Saccharomyces cerevisiae defective for nuclear fusion. Proc. Natl. Acad. Sci. USA 73:3651–3655.
   PubMed Web of Science ®Google Scholar
• Cooper, T. G. 2002. Transmitting the signal of excess nitrogen in Saccharomyces cerevisiae from the Tor proteins to the GATA factors: connecting the dots. FEMS Microbiol. Rev. 26:223–238.
   PubMed Web of Science ®Google Scholar
• Cox, B. S. 1965. PSI, a cytoplasmic suppressor of super-suppressor in yeast. Heredity 26:211–232.
   Google Scholar
• DePace, A. H., Santoso A., Hillner P., and Weissman J. S.. 1998. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93:1241–1252.
   PubMed Web of Science ®Google Scholar
• Derkatch, I. L., Bradley M. E., Hong J. Y., and Liebman S. W.. 2001. Prions affect the appearance of other prions: the story of [PIN(+)]. Cell 106:171–182.
   PubMed Web of Science ®Google Scholar
• Dobson, C. M. 1999. Protein misfolding, evolution, and disease. Trends Biochem. Sci. 24:329–332.
   PubMed Web of Science ®Google Scholar
• Doel, S. M., McCready S. J., Nierras C. R., and Cox B. S.. 1994. The dominant PNM2− mutation which eliminates the psi factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 137:659–670.
   PubMed Web of Science ®Google Scholar
• Edskes, H. K., Gray V. T., and Wickner R. B.. 1999. The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments. Proc. Natl. Acad. Sci. USA 96:1498–1503.
   PubMed Web of Science ®Google Scholar
• Edskes, H. K., and Wickner R. B.. 2000. A protein required for prion generation: [URE3] induction requires the Ras-regulated Mks1 protein. Proc. Natl. Acad. Sci. USA 97:6625–6629.
   PubMedGoogle Scholar
• Ferreira, P. C., Ness F., Edwards S. R., Cox B. S., and Tuite M. F.. 2001. The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol. Microbiol. 40:1357–1369.
   PubMed Web of Science ®Google Scholar
• Goldsbury, C. S., Cooper G. J., Goldie K. N., Muller S. A., Saafi E. L., Gruijters W. T., Misur M. P., Engel A., Aebi U., and Kistler J.. 1997. Polymorphic fibrillar assembly of human amylin. J. Struct. Biol. 119:17–27.
   PubMed Web of Science ®Google Scholar
• Hurle, M. R., Helms L. R., Li L., Chan W., and Wetzel R.. 1994. A role for destabilizing amino acid replacements in light-chain amyloidosis. Proc. Natl. Acad. Sci. USA 91:5446–5450.
   PubMed Web of Science ®Google Scholar
• Jung, G., Jones G., and Masison D. C.. 2002. Amino acid residue 184 of yeast Hsp104 chaperone is critical for prion-curing by guanidine, prion propagation, and thermotolerance. Proc. Natl. Acad. Sci. USA 99:9936–9941.
   PubMed Web of Science ®Google Scholar
• Jung, G., and Masison D. C.. 2001. Guanidine hydrochloride inhibits Hsp104 activity in vivo: a possible explanation for its effect in curing yeast prions. Curr. Microbiol. 43:7–10.
   PubMed Web of Science ®Google Scholar
• Kelly, J. W. 1998. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8:101–106.
   PubMed Web of Science ®Google Scholar
• Kisilevsky, R., and Fraser P. E.. 1997. A beta amyloidogenesis: unique, or variation on a systemic theme? Crit. Rev. Biochem. Mol. Biol. 32:361–404.
   PubMed Web of Science ®Google Scholar
• Lacroute, F. 1971. Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast. J. Bacteriol. 106:519–522.
   PubMed Web of Science ®Google Scholar
• Liebman, S. W., and Derkatch I. L.. 1999. The yeast [PSI+] prion: making sense of nonsense. J. Biol. Chem. 274:1181–1184.
   PubMed Web of Science ®Google Scholar
• Liemann, S., and Glockshuber R.. 1999. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38:3258–3267.
   PubMed Web of Science ®Google Scholar
• Maddelein, M. L., and Wickner R. B.. 1999. Two prion-inducing regions of Ure2p are nonoverlapping. Mol. Cell. Biol. 19:4516–4524.
   PubMed Web of Science ®Google Scholar
• Masison, D. C., Maddelein M. L., and Wickner R. B.. 1997. The prion model for [URE3] of yeast: spontaneous generation and requirements for propagation. Proc. Natl. Acad. Sci. USA 94:12503–12508.
   PubMed Web of Science ®Google Scholar
• Masison, D. C., and Wickner R. B.. 1995. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 270:93–95.
   PubMed Web of Science ®Google Scholar
• McCutchen, S. L., Lai Z., Miroy G. J., Kelly J. W., and Colon W.. 1995. Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease. Biochemistry 34:13527–13536.
   PubMed Web of Science ®Google Scholar
• Michelitsch, M. D., and Weissman J. S.. 2000. A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions. Proc. Natl. Acad. Sci. USA 97:11910–11915.
   PubMed Web of Science ®Google Scholar
• Ness, F., Ferreira P., Cox B. S., and Tuite M. F.. 2002. Guanidine hydrochloride inhibits the generation of prion “seeds” but not prion protein aggregation in yeast. Mol. Cell. Biol. 22:5593–5605.
   PubMed Web of Science ®Google Scholar
• Ochman, H., Gerber A. S., and Hartl D. L.. 1988. Genetic applications of an inverse polymerase chain reaction. Genetics 120:621–623.
   PubMed Web of Science ®Google Scholar
• Paushkin, S. V., Kushnirov V. V., Smirnov V. N., and Ter-Avanesyan M. D.. 1996. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J. 15:3127–3134.
   PubMed Web of Science ®Google Scholar
• Perrett, S., Freeman S. J., Butler P. J., and Fersht A. R.. 1999. Equilibrium folding properties of the yeast prion protein determinant Ure2. J. Mol. Biol. 290:331–345.
   PubMed Web of Science ®Google Scholar
• Ridley, S. P., Sommer S. S., and Wickner R. B.. 1984. Superkiller mutations in Saccharomyces cerevisiae suppress exclusion of M2 double-stranded RNA by L-A-HN and confer cold sensitivity in the presence of M and L-A-HN. Mol. Cell. Biol. 4:761–770.
   PubMed Web of Science ®Google Scholar
• Ripaud, L., Maillet L., and Cullin C.. 2003. The mechanisms of [URE3] prion elimination demonstrate that large aggregates of Ure2p are dead-end products. EMBO J. 22:5251–5259.
   PubMedGoogle Scholar
• Roberts, B. T., and Wickner R. B.. 2003. Heritable activity: a prion that propagates by covalent autoactivation. Genes Dev. 17:2083–2087.
   PubMed Web of Science ®Google Scholar
• Santoso, A., Chien P., Osherovich L. Z., and Weissman J. S.. 2000. Molecular basis of a yeast prion species barrier. Cell 100:277–288.
   PubMed Web of Science ®Google Scholar
• Sherman, F. 1991. Getting started with yeast. Methods Enzymol. 194:3–21.
   PubMed Web of Science ®Google Scholar
• Sipe, J. D., and Cohen A. S.. 2000. Review: history of the amyloid fibril. J. Struct. Biol. 130:88–98.
   PubMed Web of Science ®Google Scholar
• Sondheimer, N., and Lindquist S.. 2000. Rnq1: an epigenetic modifier of protein function in yeast. Mol. Cell 5:163–172.
   PubMed Web of Science ®Google Scholar
• Speransky, V. V., Taylor K. L., Edskes H. K., Wickner R. B., and Steven A. C.. 2001. Prion filament networks in [URE3] cells of Saccharomyces cerevisiae. J. Cell Biol. 153:1327–1336.
   PubMedGoogle Scholar
• Taylor, K. L., Cheng N., Williams R. W., Steven A. C., and Wickner R. B.. 1999. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science 283:1339–1343.
   PubMed Web of Science ®Google Scholar
• Ter-Avanesyan, M. D., Dagkesamanskaya A. R., Kushnirov V. V., and Smirnov V. N.. 1994. The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics 137:671–676.
   PubMed Web of Science ®Google Scholar
• Tuite, M. F., Mundy C. R., and Cox B. S.. 1981. Agents that cause a high frequency of genetic change from [psi+] to [psi-] in Saccharomyces cerevisiae. Genetics 98:691–711.
   PubMed Web of Science ®Google Scholar
• Turoscy, V., and Cooper T. G.. 1987. Ureidosuccinate is transported by the allantoate transport system in Saccharomyces cerevisiae. J. Bacteriol. 169:2598–2600.
   PubMedGoogle Scholar
• Umland, T. C., Taylor K. L., Rhee S., Wickner R. B., and Davies D. R.. 2001. The crystal structure of the nitrogen regulation fragment of the yeast prion protein Ure2p. Proc. Natl. Acad. Sci. USA 98:1459–1464.
   PubMed Web of Science ®Google Scholar
• Wegrzyn, R. D., Bapat K., Newnam G. P., Zink A. D., and Chernoff Y. O.. 2001. Mechanism of prion loss after Hsp104 inactivation in yeast. Mol. Cell. Biol. 21:4656–4669.
   PubMed Web of Science ®Google Scholar
• Wickner, R. B. 1994. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264:566–569.
   PubMed Web of Science ®Google Scholar